February 10, 2016
Recommended Topic Related To:


"On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need f"...




To assure the safe and effective use of Provocholine® (methacholine chloride) inhalation challenge, the following instructions and information should be given to patients:

Patients should be instructed regarding symptoms that may occur as a result of the test and how such symptoms can be managed.

A female patient should inform her physician if she is pregnant, or the date of her last onset of menses, or the date and result of her last pregnancy test. (See PRECAUTIONS: Pregnancy.)

Last reviewed on RxList: 9/25/2008
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.